Na Zhao
- Cancer Research top 5%
- MicroRNA in disease regulation 13
- NF-κB Signaling Pathways 6
- Cancer-related molecular mechanisms research 6
- Molecular Biology top 5%
- Histone Deacetylase Inhibitors Research 12
- Protein Degradation and Inhibitors 10
- RNA modifications and cancer 9
- Circular RNAs in diseases 9
- Cell Biology top 5%
-
- Peptidase Inhibition and Analysis 7
Na Zhao
104 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 133
- Cancer Research 588
- Molecular Biology 1.3k
- Cell Biology 284
- Complementary and alternative medicine 135
- Endocrinology, Diabetes and Metabolism 205
Countries citing papers authored by Na Zhao
This map shows the geographic impact of Na Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Na Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Na Zhao more than expected).
Fields of papers citing papers by Na Zhao
This network shows the impact of papers produced by Na Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Na Zhao. The network helps show where Na Zhao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Na Zhao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 3 | |
| 8 | 2024 | 3 | |
| 9 | 2024 | 1 | |
| 10 | 2023 | 3 | |
| 11 | 2023 | 1 | |
| 12 | 2023 | 31 | |
| 13 | 2021 | 43 | |
| 14 | 2021 | 31 | |
| 15 | 2020 | 7 | |
| 16 | 2019 | 17 | |
| 17 | 2019 | 54 | |
| 18 | 2017 | 5 | |
| 19 | 2016 | 13 | |
| 20 | 2013 | 61 |
About Na Zhao
Na Zhao is a scholar working on Cancer Research, Molecular Biology and Complementary and alternative medicine, having authored 119 papers that have together received 2.6k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (13 papers), Histone Deacetylase Inhibitors Research (12 papers), Protein Degradation and Inhibitors (10 papers), RNA modifications and cancer (9 papers), Circular RNAs in diseases (9 papers), Peptidase Inhibition and Analysis (7 papers), NF-κB Signaling Pathways (6 papers) and Cancer-related molecular mechanisms research (6 papers). The work is most often cited by research in Cancer Research (588 citations), Molecular Biology (1.3k citations) and Cell Biology (284 citations). Na Zhao has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Shi‐Mei Zhuang, Yifei Lv, Ruizhi Wang, Feifei Yang, Guohong Xie, Qingxiang Zhou, Ying Zhu, Jian‐Hong Fang, Di Ge and Yihua Chen. Their work appears in journals such as Evidence-based Complementary and Alternative Medicine, Toxicon, Hepatology, Cell Death and Disease and Frontiers in Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.